Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Quanterix
One Kendall Square, Suite B14201
Cambridge, MA 2130
Phone: 617-301-9400
http://www.quanterix.com/

Quanterix Corporation is developing its proprietary Single Molecule Array (SiMoA) technology for the in vitro diagnostics and life science research markets. The digital nature of SiMoA yields unprecedented assay performance, stemming from a 1,000-fold improvement in sensitivity compared with today's analog only technology. SiMoA will enable researchers in life science to validate novel, low abundance biomolecules from a single droplet of blood, leading to greater insight into disease detection, diagnosis, therapy selection and disease monitoring.

Key Contact
Name
Martin Madaus
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
01/05/12 undisclosed Strategic In-Q-Tel
undisclosed
03/06/12 $2,000,000
11/15/12 $18,500,000 Series C ARCH Venture Partners
bioMerieux
Flagship Ventures
In-Q-Tel
undisclosed
03/23/16 $46,000,000 Series D ARCH Venture Partners
Cormorant Asset Management
Dr. David Walt
Hercules Technology Growth Capital
Trinitas Capital
Tufts University
undisclosed
08/03/17 $8,500,000 T. Rowe Price
undisclosed